HEcoPerMed

HEcoPerMed stands for “Health Economics for Personalised Medicine". Project funded by EU H2020 under Grant Agreement No 824997.

[HEcoPerMed @hecopermed]

The special issue dedicated to the HEcoPerMed project is available online in the Journal of Personalized Medicine.

@iMTAnews @DLR_en @HERC_Oxford @ICPerMed @futuresciencegp @fsgpme

#healtheconomics #personalisedmedicine

[HEcoPerMed @hecopermed]

@iMTAnews @DLR_en @HERC_Oxford @ICPerMed @EPPerMed @futuresciencegp @fsgpme 5/5 the third most read article is the cost-effectiveness study of extended DPYD testing prior to fluoropyrimidine chemotherapy in metastatic breast cancer https://t.co/bkuKSh1ABi

[HEcoPerMed @hecopermed]

According to the foreword published in the Journal of Personalized Medicine, "Looking back over 2023 and welcome to the 21st issue of Personalized Medicine", @hecopermed Special Focus Issue has generated a lot of interest with papers featured in the most read and cited articles🧵

[HEcoPerMed @hecopermed]

@iMTAnews @DLR_en @HERC_Oxford @ICPerMed @EPPerMed @futuresciencegp @fsgpme 4/5 the most read Editorial is the introduction to the HecoPerMed Special Focus Issue https://t.co/5E1WLuB9ew

[HEcoPerMed @hecopermed]

Access the special issue here -> https://t.co/lUzKyEtusK

[HEcoPerMed @hecopermed]

@ICPerMed: Researchers from the HEcoPerMed consortium published a special issue of Future Medicine / Personalised Medicine

@iMTAnews @DLR_en @HERC_Oxford @futuresciencegp @fsgpme

#healtheconomics #personalisedmedicine

https://t.co/vAz087DfZ7

[HEcoPerMed @hecopermed]

We would like to thank all experts in the field of personalised medicine who attended our workshops and conference, and supported us.

[HEcoPerMed @hecopermed]

The special issue dedicated to the HEcoPerMed project is available online in the Journal of Personalized Medicine.

@iMTAnews @DLR_en @HERC_Oxford @ICPerMed @futuresciencegp @fsgpme

#healtheconomics #personalisedmedicine

[HEcoPerMed @hecopermed]

https://t.co/HzWMPnZswh

[HEcoPerMed @hecopermed]

#ISPOREurope Vienna Workshop "Is There Large Underused Potential in Using Genetic Tests to Better Stratify Patients to Established Therapies?”.
Monday 7 Nov, 16.30-17.30.
@iMTAnews @HERC_Oxford #SyreonResearchInstitute

[HEcoPerMed @hecopermed]

HEcoPerMed team is going to #ISPOREurope in Vienna to present "Is There Large Underused Potential in Using Genetic Tests to Better Stratify Patients to Established Therapies?”.
Join our workshop on Monday 7 Nov, 16.30-17.30.

@iMTAnews @HERC_Oxford @ICPerMed

[HEcoPerMed @hecopermed]

NEW PUBLICATION

Cost-Effectiveness Analysis of Treating Patients With NTRK-Positive Cancer With the Histology-Independent Therapy Entrectinib

@iMTAnews #SyreonResearchInstitute @HERC_Oxford @ICPerMed

#healtheconomics

https://t.co/PYXbFrMTqM